Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
META-D: Switch to Delstrigo in Virally Suppressed HIV Patients
NCT05289986Phase 4Terminated
- Sponsor
- Chelsea and Westminster Hospital NHS Foundation Trust
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doravirine in human immunodeficiency virus infection (HIV), sponsored by Chelsea and Westminster Hospital NHS Foundation Trust. Started Nov 2023; status: terminated.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05289986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05289986.